MENU
+Compare
NVS
Stock ticker: NYSE
AS OF
Oct 22 closing price
Price
$131.43
Change
+$0.09 (+0.07%)
Capitalization
256.12B

NVS Novartis AG Forecast, Technical & Fundamental Analysis

Novartis develops and manufactures innovative drugs... Show more

NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NVS with price predictions
Oct 22, 2025

NVS in +0.78% Uptrend, rising for three consecutive days on October 20, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NVS advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The 10-day RSI Indicator for NVS moved out of overbought territory on October 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where NVS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on October 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NVS as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NVS turned negative on October 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NVS broke above its upper Bollinger Band on September 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.061) is normal, around the industry mean (9.693). P/E Ratio (19.159) is within average values for comparable stocks, (24.251). Projected Growth (PEG Ratio) (1.368) is also within normal values, averaging (1.906). Dividend Yield (0.030) settles around the average of (0.028) among similar stocks. P/S Ratio (4.748) is also within normal values, averaging (3.519).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NVS is expected to report earnings to fall 6.20% to $2.27 per share on October 28

Novartis AG NVS Stock Earnings Reports
Q3'25
Est.
$2.27
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.20
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.12
The last earnings report on July 17 showed earnings per share of $2.42, beating the estimate of $2.35. With 1.03M shares outstanding, the current market capitalization sits at 256.12B.
A.I.Advisor
published Dividends

NVS paid dividends on March 20, 2023

Novartis AG NVS Stock Dividends
А dividend of $3.70 per share was paid with a record date of March 20, 2023, and an ex-dividend date of March 09, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health care and nutritional products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lichtstrasse 35
Phone
+41 613241111
Employees
76057
Web
https://www.novartis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VGIT60.54N/A
N/A
Vanguard Intmdt-Term Trs ETF
DIVZ35.89-0.11
-0.30%
Opal Dividend Income ETF
EOI20.39-0.12
-0.59%
Eaton Vance Enhanced Equity Income Fund
CBLS27.84-0.52
-1.84%
Clough Hedged Equity ETF
AAPW40.51-0.94
-2.27%
Roundhill AAPL WeeklyPay ETF

NVS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.07%
GSK - NVS
69%
Closely correlated
+0.73%
AZN - NVS
62%
Loosely correlated
+0.25%
PFE - NVS
60%
Loosely correlated
-0.52%
JNJ - NVS
54%
Loosely correlated
+0.55%
SNY - NVS
50%
Loosely correlated
+0.66%
More

Groups containing NVS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+0.07%
NVS
(2 stocks)
97%
Closely correlated
+0.40%